Of 1,502 studies with a Saudi site registered on ClinicalTrials.gov to August 2025, three quarters were interventional, most were sponsored by non-industry bodies, activity clustered in Riyadh, and only 12.1% had posted results.
Published as "Trends in clinical research in Saudi Arabia: A registry-based descriptive analysis of ClinicalTrials.gov to 2025". A descriptive analysis of every study registered on ClinicalTrials.gov with at least one Saudi site through August 2025, by sponsor, design, phase, enrolment, city and therapeutic area.
Saudi Arabia increasingly joins multinational late-phase trials, but early-phase capacity, research outside the big cities and results reporting lag.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/